Tirabrutinib is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells.
Molecular Weight
454.48
Molecular Formula
C25H22N6O3
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Tirabrutinib is used to research its effects on B-cell malignancies through the inhibition of BTK signaling pathways.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
